Skip to main content

DNB Asset Management AS

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1456670 Oslo, Q8

Position in XENE

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$10,530,092
-$1,698,193 QoQ
Shares Held
181,085
-33.6% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DNB Asset Management AS holds $242,159,625 across 67 Biotechnology names. XENE ranks #5 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 XENE
Xenon Pharmaceuticals Inc.
This page
181,085 $10,530,092

All Filings in XENE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,530,092 181,085
2025-12-31 $12,228,285 272,831
2025-09-30 $10,000,602 249,081
2025-06-30 $7,329,114 234,157
2025-03-31 $7,699,121 229,482
2024-12-31 $7,967,125 203,243
2024-09-30 $7,504,827 190,623
2024-06-30 $6,851,829 175,733
2024-03-31 $5,435,062 126,250
2023-12-31 $5,820,832 126,375
2023-09-30 $4,159,663 121,770
2023-06-30 $4,336,216 112,629
2023-03-31 $3,538,163 98,859
2022-12-31 $3,728,145 94,551